人才队伍

您当前的位置: 首页 > 人才队伍 > 副教授

龚萌  

Meng Gong  


职称:副研究员,硕士生导师

研究方向:代谢组学、疾病与代谢调控、肿瘤转移与复发以及天然药物、食品与环境对机体代谢影响

教育、工作经历:

2000年本科毕业于四川大学生命科学学院生物化学专业;2006年于四川大学华西临床医学院卫生部移植工程与移植免疫重点实验室获得医学遗传学博士学位;于2006-2008年在华西医院从事博士后研究,2009年留院工作。2009-2011年由医院派遣赴美国东缅因医学中心缅因人类遗传与健康研究所及Jackson实验室从事博士后研究工作。2016年11月至2017年3月再次赴美国华盛顿大学开展访问学习。为四川大学华西医院蛋白组与代谢组学开发技术平台主要创始人,现任代谢组学平台主管。

学术/科研成果:

主持国家自然科学基金NSFC青年基金、四川省科技厅国际合作基金项目、成都市科技局转化医学基金、中国博士后基金。作为主研人员,参与卫生部临床重点专科重点实验室建设项目、NSFC面上项目和四川省科技厅项目等10余项研究。以第一或通讯作者,在Neuro-oncology、Analytical Chemistry、Molecular Cancer Research等杂志发表SCI论文10余篇,总计发表论文近40篇。作为发明人,申报发明专利6项,已获授权2项。


Title: Associate Professor, Master Supervisor

Research Interests: metabolomics, disease and metabolic regulation, tumor metastasis and recurrence, and the influence of natural medicine, food and environment on body metabolism

Education and work experience:

In 2000, he graduated from the College of Life Sciences, Sichuan University, majoring in biochemistry; in 2006, he obtained a doctorate degree in medical genetics from the Key Laboratory of Transplantation Engineering and Transplant Immunity of the Ministry of Health, West China Clinical School of Sichuan University; engaged in postdoctoral research in West China Hospital from 2006 to 2008 and stayed in hospital in 2009. From 2009 to 2011, he was dispatched by the hospital to the Maine Institute of Human Genetics and Health of the Eastern Maine Medical Center and Jackson Laboratory for post-doctoral research. From November 2016 to March 2017, he went to the University of Washington again for visiting study. He is the main founder of the proteomics and metabolomics development technology platform of West China Hospital of Sichuan University, and the current director of the metabolomics platform.

Research and Achievements:

Presided over the National Natural Science Foundation of China NSFC Youth Fund, Sichuan Provincial Department of Science and Technology International Cooperation Fund Project, Chengdu Science and Technology Bureau Translational Medicine Fund, and China Postdoctoral Fund. As the lead researcher, he participated in more than 10 researches including the Ministry of Health's key clinical specialty laboratory construction project, the NSFC general-purpose project, and the Sichuan Provincial Department of Science and Technology project. As the first or corresponding author, he has published more than 10 SCI papers in Neuro-oncology, Analytical Chemistry, Molecular Cancer Research and other journals, with a total of nearly 40 papers published. As an inventor, he has declared 6 invention patents and 2 of them have been authorized.